Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31946

1.

Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.

Wei Y, Xu N, Chen SH, Li XD, Zheng QS, Lin YZ, Xue XY.

Int Braz J Urol. 2016 Jul-Aug;42(4):747-756. doi: 10.1590/S1677-5538.IBJU.2015.0225.

PMID:
27564286
2.

Predictive risk factors of postoperative urinary incontinence following holmium laser enucleation of the prostate during the initial learning period.

Kobayashi S, Yano M, Nakayama T, Kitahara S.

Int Braz J Urol. 2016 Jul-Aug;42(4):740-746. doi: 10.1590/S1677-5538.IBJU.2015.0477.

PMID:
27564285
3.

Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer.

Chen Y, Yu W, Fan Y, Zhou L, Yang Y, Wang H, Jiang Y, Wang X, Wu S, Jin J.

Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11559. [Epub ahead of print]

PMID:
27564265
4.

Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX.

Almasi F, Mousavi Gargari SL, Bitaraf F, Rasoulinejad S.

Avicenna J Med Biotechnol. 2016 Jul-Sep;8(3):104-11.

PMID:
27563422
5.

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer.

Johnson JK, Skoda EM, Zhou J, Parrinello E, Wang D, O'Malley K, Eyer BR, Kazancioglu M, Eisermann K, Johnston PA, Nelson JB, Wang Z, Wipf P.

ACS Med Chem Lett. 2016 May 27;7(8):785-90. doi: 10.1021/acsmedchemlett.6b00186. eCollection 2016 Aug 11.

PMID:
27563404
6.

An integrated lab-on-a-chip-based electrochemical biosensor for rapid and sensitive detection of cancer biomarkers.

Uludag Y, Narter F, Sağlam E, Köktürk G, Gök MY, Akgün M, Barut S, Budak S.

Anal Bioanal Chem. 2016 Aug 25. [Epub ahead of print]

PMID:
27562751
7.

[Current aspects of prostate cancer screening].

Jalón Monzón A, Escaf Barmadah S, Viña Alonso LM, Jalón Monzón M.

Semergen. 2016 Aug 22. pii: S1138-3593(16)30134-4. doi: 10.1016/j.semerg.2016.07.002. [Epub ahead of print] Spanish.

PMID:
27562331
8.

Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?

Kishan AU, Duchesne G, Wang PC, Rwigema JM, Saigal C, Rettig M, Steinberg ML, King CR.

Am J Clin Oncol. 2016 Aug 24. [Epub ahead of print]

PMID:
27560157
9.

Comparison of <sup>68</sup>Ga-labelled PSMA-11 and <sup>11</sup>C-choline in the detection of prostate cancer metastases by PET/CT.

Schwenck J, Rempp H, Reischl G, Kruck S, Stenzl A, Nikolaou K, Pfannenberg C, la Fougère C.

Eur J Nucl Med Mol Imaging. 2016 Aug 24. [Epub ahead of print]

PMID:
27557844
10.

Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.

Lee JK, Lee S, Hong SK, Byun SS, Lee SE.

BMC Urol. 2016 Aug 24;16(1):51. doi: 10.1186/s12894-016-0169-z.

PMID:
27557527
11.

Prostate cancer.

Castillejos-Molina RA, Gabilondo-Navarro FB.

Salud Publica Mex. 2016 Apr;58(2):279-84.

12.

Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.

Shetty D, Loh H, Bui C, Mansberg R, Hadjashrafi A, Do V.

Clin Nucl Med. 2016 Aug 24. [Epub ahead of print]

PMID:
27556788
13.

Carcinoma en cuirasse caused by pleomorphic lobular carcinoma of the breast in a man.

Lauren CT, Antonov NK, McGee JS, de Vinck DC, Hibshoosh H, Grossman ME.

JAAD Case Rep. 2016 Aug 13;2(4):317-9. doi: 10.1016/j.jdcr.2016.06.006. eCollection 2016 Jul. No abstract available.

14.

Assessment of the performance of Partin's nomogram (2007) in contemporary Indian cohort.

Yadav R, Arora S, Sachdeva M, Gupta NP.

Indian J Urol. 2016 Jul-Sep;32(3):199-203. doi: 10.4103/0970-1591.185096.

15.

ANNALS EXPRESS: Frequency of KLK3 gene deletions in the general population.

Rodriguez S, Al-Ghamdi O, Guthrie P, Shihab H, McArdle W, Gaunt T, Alharbi K, Day I.

Ann Clin Biochem. 2016 Aug 23. pii: 0004563216666999. [Epub ahead of print]

PMID:
27555663
16.

Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.

Kratochwil C, Afshar-Oromieh A, Kopka K, Haberkorn U, Giesel FL.

Semin Nucl Med. 2016 Sep;46(5):405-18. doi: 10.1053/j.semnuclmed.2016.04.004. Review.

PMID:
27553466
17.

Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.

Choi HM, Jung Y, Park J, Kim HL, Youn DH, Kang J, Jeong MY, Lee JH, Yang WM, Lee SG, Ahn KS, Um JY.

Sci Rep. 2016 Aug 23;6:31906. doi: 10.1038/srep31906.

18.

Oligometastatic prostate cancer: Metastases-directed therapy?

Van Poppel H, De Meerleer G, Joniau S.

Arab J Urol. 2016 Jul 20;14(3):179-82. doi: 10.1016/j.aju.2016.06.004. eCollection 2016 Sep. Review.

19.

Weight Management to Reduce Prostate Cancer Risk: A Survey of Men's Needs and Interests.

Schleper A, Sullivan DK, Thrasher JB, Holzbeierlein JM, Klemp J, Befort C, Hamilton-Reeves JM.

Cancer Clin Oncol. 2016 May;5(1):43-52.

20.

Active surveillance or radical prostatectomy? Which treatment is best?

Caliskan S, Keles MO, Kaba S, Koca O, Akyuz M, Ozturk MI, Karaman MI.

Bratisl Lek Listy. 2016;117(8):468-71.

PMID:
27546700
Items per page

Supplemental Content

Loading ...
Write to the Help Desk